Literature DB >> 30417864

Antigenic Liposomes for Generation of Disease-specific Antibodies.

Kyle J Bednar1, Lakeya Hardy2, Johanna Smeekens3, Dharmendra Raghuwanshi4, Shiteng Duan5, Mike D Kulis3, Matthew S Macauley6.   

Abstract

Antibody responses provide critical protective immunity to a wide array of pathogens. There remains a high interest in generating robust antibodies for vaccination as well as understand how pathogenic antibody responses develop in allergies and autoimmune disease. Generating robust antigen-specific antibody responses is not always trivial. In mouse models, it often requires multiple rounds of immunizations with adjuvant that leads to a great deal of variability in the levels of induced antibodies. One example is in mouse models of peanut allergies where more robust and reproducible models that minimize mouse numbers and the use of adjuvant would be beneficial. Presented here is a highly reproducible mouse model of peanut allergy anaphylaxis. This new model relies on two key factors: (1) antigen-specific splenocytes are adoptively transferred from a peanut-sensitized mouse into a naïve recipient mouse, normalizing the number of antigen-specific memory B- and T-cells across a large number of mice; and (2) recipient mice are subsequently boosted with a strong multivalent immunogen in the form of liposomal nanoparticles displaying the major peanut allergen (Ara h 2). The major advantage of this model is its reproducibility, which ultimately lowers the number of animals used in each study, while minimizing the number of animals receiving multiple injections of adjuvant. The modular assembly of these immunogenic liposomes provides relatively facile adaptability to other allergic or autoimmune models that involve pathogenic antibodies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30417864      PMCID: PMC6235598          DOI: 10.3791/58285

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  27 in total

1.  Site-selective protein-modification chemistry for basic biology and drug development.

Authors:  Nikolaus Krall; Filipa P da Cruz; Omar Boutureira; Gonçalo J L Bernardes
Journal:  Nat Chem       Date:  2015-11-30       Impact factor: 24.427

2.  Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.

Authors:  Edwin H Kim; J Andrew Bird; Michael Kulis; Susan Laubach; Laurent Pons; Wayne Shreffler; Pamela Steele; Janet Kamilaris; Brian Vickery; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

Review 3.  B cells and autoimmunity.

Authors:  Shiv Pillai; Hamid Mattoo; Annaiah Cariappa
Journal:  Curr Opin Immunol       Date:  2011-11-24       Impact factor: 7.486

4.  A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.

Authors:  Pooja Varshney; Stacie M Jones; Amy M Scurlock; Tamara T Perry; Alex Kemper; Pamela Steele; Anne Hiegel; Janet Kamilaris; Suzanne Carlisle; Xiaohong Yue; Mike Kulis; Laurent Pons; Brian Vickery; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

5.  Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

Authors:  Kamal D Srivastava; Alyssa Siefert; Tarek M Fahmy; Michael J Caplan; Xiu-Min Li; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2016-04-26       Impact factor: 10.793

6.  Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

Authors:  Brian P Vickery; Amy M Scurlock; Michael Kulis; Pamela H Steele; Janet Kamilaris; Jelena P Berglund; Caitlin Burk; Anne Hiegel; Suzanna Carlisle; Lynn Christie; Tamara T Perry; Robbie D Pesek; Saira Sheikh; Yamini Virkud; P Brian Smith; Mohamed H Shamji; Stephen R Durham; Stacie M Jones; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2013-12-19       Impact factor: 10.793

7.  Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes.

Authors:  Moon Sen; Randall Kopper; Laurent Pons; Edathara C Abraham; A Wesley Burks; Gary A Bannon
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

8.  Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis.

Authors:  Matthew S Macauley; Fabian Pfrengle; Christoph Rademacher; Corwin M Nycholat; Andrew J Gale; Annette von Drygalski; James C Paulson
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

Review 9.  Animal models of myasthenia gravis: utility and limitations.

Authors:  Renato Mantegazza; Chiara Cordiglieri; Alessandra Consonni; Fulvio Baggi
Journal:  Int J Gen Med       Date:  2016-03-04

10.  Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.

Authors:  P W Berman; J Patrick
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  5 in total

1.  Indoor dust acts as an adjuvant to promote sensitization to peanut through the airway.

Authors:  Johanna M Smeekens; Robert M Immormino; Peter A Balogh; Scott H Randell; Michael D Kulis; Timothy P Moran
Journal:  Clin Exp Allergy       Date:  2019-09-10       Impact factor: 5.018

2.  Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.

Authors:  Shiteng Duan; Britni M Arlian; Corwin M Nycholat; Yadong Wei; Hiroaki Tateno; Scott A Smith; Matthew S Macauley; Zhou Zhu; Bruce S Bochner; James C Paulson
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.422

3.  Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible Mice.

Authors:  Johanna M Smeekens; Brandi T Johnson-Weaver; Andrew L Hinton; M Andrea Azcarate-Peril; Timothy P Moran; Robert M Immormino; Janelle R Kesselring; Erin C Steinbach; Kelly A Orgel; Herman F Staats; A Wesley Burks; Peter J Mucha; Martin T Ferris; Michael D Kulis
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

4.  Model of Walnut Allergy in CC027/GeniUnc Mice Recapitulates Key Features of Human Disease.

Authors:  Johanna M Smeekens; Kelly A Orgel; Janelle Kesselring; Ken Bagley; Michael D Kulis
Journal:  Yale J Biol Med       Date:  2020-12-29

5.  Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy.

Authors:  Jada Suber; Yugen Zhang; Ping Ye; Rishu Guo; A Wesley Burks; Michael D Kulis; Scott A Smith; Onyinye I Iweala
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.